CIK: 1190270 - Address: C/o Nvidia Corporation, 2788 San Tomas Expressway, Santa Clara, CA 95051
34 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret212337-15-13-0
P%wins10050500505050
S%ret217-018-1193911
S%wins86291457293341

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/3/24 16:27
4/2/24
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS-6,215887.890-7-5132I
2/27/24 17:06
2/23/24
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS-11,947796.450-15-10139I
2/28/23 16:59
2/27/23
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS-4,727236.370-20-12153I
6/16/22 18:38
6/14/22
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPerry Mark LCADM.d00.00041138D
3/21/22 18:16
3/18/22
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS-4,410263.800-17-9172D
6/21/21 16:27
6/17/21
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPerry Mark LCADM.d00.00031034D
4/6/21 16:55
4/5/21
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS-3,397556.580-6-1247D
6/23/20 18:25
6/13/20
MYOKMyokardia, Inc.DEHealthDrugPharmaceutical PreparationsPerry Mark LCADM.ad00.0002928D
6/19/20 21:33
6/17/20
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPerry Mark LCADM.d00.00051831D
6/16/20 18:03
6/13/20
MYOKMyokardia, Inc.DEHealthDrugPharmaceutical PreparationsPerry Mark LCADM.d00.0002928D
5/29/20 18:29
5/27/20
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS-4,069333.310-12-1952D
5/13/20 18:07
5/12/20
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPerry Mark LCADM.d1,18222.0405426D
5/13/20 18:07
5/12/20
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPerry Mark LCADS.d-4,18678.100-54-6726D
2/20/20 17:59
2/18/20
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS-2,557292.130-9-1264D
2/13/18 19:03
2/12/18
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS-3,945227.930-17-2071D
8/16/17 16:07
8/14/17
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS-2,641162.240-16-1688D
7/15/16 16:41
7/13/16
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADM.d62217.78333545112D1841748345131013211192696
7/15/16 16:41
7/13/16
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS.d-1,85252.9333-35-24112D1841748345131013211192696
1/7/16 21:43
8/17/15
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPerry Mark LCADP10020.001152326D-50-52-28-29-264-5-16-13-23-26
11/16/15 16:38
11/12/15
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADM.d49812.46334061106D915541281756-3049-941182
11/16/15 16:38
11/12/15
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS.d-1,22030.4933-40-27106D915541281756-3049-941182
11/5/15 20:38
11/3/15
MYOKMyokardia IncDEHealthDrugPharmaceutical PreparationsPerry Mark LCADP5010.00452525D-111029-162131
2/18/15 16:29
2/18/15
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADM.d4649.67334810096D83271915131498014-3727
2/18/15 16:29
2/18/15
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS.d-1,06522.2033-48-3396D83271915131498014-3727
4/8/11 18:49
4/6/11
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADM.d1,4828.473317550D59769-6-223-63-1512-12-20-17
4/8/11 18:49
4/6/11
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADS.d-3,04617.4133-175-7850D59769-6-223-63-1512-12-20-17
1/23/08 13:10
1/18/08
NVDANvidia CorpDETechSemicnSemiconductors & Related DeviPerry Mark LCADM.d4248.473350New50D5711-22-37-30-31-17028-10-17-52-68
10/2/06 18:06
9/28/06
NUVONuvelo IncDEHealthDiagnIn Vitro & In Vivo DiagnosticPerry Mark LCADM5979.07066New66D
2/4/04 18:32
2/3/04
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagPerry Mark LCAOEVP OperM.d76814.76335235202M6163-143-5-8-15-702-141216
2/4/04 18:32
2/3/04
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagPerry Mark LCAOEVP OperS.d-2,81456.6033-50-20202M6163-143-5-8-15-702-141216
11/3/03 20:09
10/31/03
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagPerry Mark LCAOEVP OperM64214.59334428199D735717-16-5-11-6-8-2-392629
11/3/03 20:09
10/31/03
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagPerry Mark LCAOEVP OperS-2,39654.4633-44-18199D735717-16-5-11-6-8-2-392629
8/7/03 17:53
8/5/03
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagPerry Mark LCAOEVP OperM.m81012.65336449194D13999833515-6-11-5-107-15-11-2
8/7/03 17:53
8/5/03
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagPerry Mark LCAOEVP OperS.m-3,37664.5033-52-21194D13999833515-6-11-5-107-15-11-2

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact